药明生物(02269)根据首次公开发售前购股权计划发行405.5万股

Core Viewpoint - WuXi Biologics (02269) announced the issuance of a total of 4.055 million ordinary shares on November 10, 2025, as part of the exercise of options under its pre-IPO share option plan adopted on January 5, 2016, and revised on August 10, 2016 [1] Summary by Category - Company Actions - The company is exercising options that will result in the issuance of 4.055 million ordinary shares [1]